Oesophageal manometry in early and definite systemic sclerosis

Clinical Rheumatology

Volumn 24, Issue 4, 2005, Pages 370-376

  Airò, Paolo ^a,b   Della Casa, Domenico ^a   Danieli, Elisabetta ^a   Missale, Guido ^a   Cattaneo, Roberto ^a   Cestari, Renzo ^a  

^a SPEDALI CIVILI   (Italy)

^b Spedali Civili   (Italy)

Author keywords

Classification criteria; Oesophageal manometry; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY; DNA TOPOISOMERASE;

ADULT; ANTIBODY DETECTION; ARTICLE; CAPILLAROSCOPY; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; EARLY DIAGNOSIS; ESOPHAGUS DISEASE; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOWER ESOPHAGUS SPHINCTER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT SELECTION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SYNDROME CREST; SYSTEMIC SCLEROSIS;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; COHORT STUDIES; COMORBIDITY; ESOPHAGEAL MOTILITY DISORDERS; FEMALE; HUMANS; INCIDENCE; MALE; MANOMETRY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 23344451553     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1049-6     Document Type: Article

References (43)

1. Sjoegren R (1994) Gastrointestinal motility disorders in systemic sclerosis. Arthritis Rheum 37:1265-1282 7945489
2. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581-590
3. Kallenberg CGM, Wouda AA, Hoet HM, van Venroij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud's phenomenon: A six-year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634-641 1:STN:280:BieA38rms1M%3D
4. Weiner ES, Hildebrandt S, Senecal JL et al (1991) Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis Rheum 34:68-77 1:STN:280:By6D1czntlM%3D
5. TA Medsger Jr 1985 Comment on scleroderma criteria cooperative study In: CM Black AR Myers (eds.) Current topics in rheumatology: Systemic sclerosis (scleroderma). Gower Medical Publishing New York 16-17
6. Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735-736 11263791
7. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573-1576 1:STN:280:DC%2BD38%2Fit1Oqsw%3D%3D
8. Wigley FM (2001) When is scleroderma really scleroderma? J Rheumatol 28:1471-1473 1:STN:280:DC%2BD38%2Fit1Oktg%3D%3D
9. LeRoy EC, Black C, Fleischmayer R et al (1988) Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15:202-208 1:STN:280:BieB3c%2FhsVQ%3D
10. Maricq HR (1981) Wide-field capillary microscopy: Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24:1159-1165 1:STN:280:Bi2D28fmt1I%3D
11. Maricq HR, Harper FE, Khan EM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195-205 1:STN:280:BiqC2sjnvVU%3D
12. Bernstein RM, Bunn CC, Hughes GRV (1982) Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 41:554-555 1:STN:280:BiyD387ktF0%3D
13. Pope CE II (1992) The quality of life following antireflux surgery. World J Surg 16:335-358 1561819
14. Henry MACA, Harbermann MC, Rocha OM (1999) Esophageal motor disturbance in progressive systemic sclerosis. Dis Esophagus 12:51-53 1:STN:280:DC%2BD3cvhtVCksg%3D%3D
15. Dodds WJ, Hogan WJ, Steff JJ, Miller WN, Arndorfer RC (1975) A rapid pull-through technique for measuring lower esophageal sphincter pressure. Gastroenterology 68:437-443 1:STN:280:CSqD1Mvhtlw%3D
16. Bassotti G, Bacci G, Biagini D, David P, Alunni G, Pelli MA (1988) Manometric evaluation of the entire esophagus in healthy subjects and patients with high amplitude peristaltic contractions. Dysphagia 3:93-96 1:STN:280:By%2BC2M7isFU%3D
17. Winans CS, Harris LD (1967) Quantitation of lower esophageal sphincter competence. Gastroenterology 52:773-778 1:STN:280:CCiC3sjlsVQ%3D
18. Castell JA (1987) The computer in the motility laboratory. In: Castell DO, Richetr JE, Dalton CB (eds) Esophageal motility testing. Elsevier, New York
19. Doria A, Bonavina L, Anselmino M et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685-690 1:STN:280:By6A38rhvVY%3D
20. Orlowski J, Dodds WJ, Linehan JH, Dent J, Hogan WJ, Amdorfer RC (1982) Requirements for accurate manometric recording of pharyngeal and esophageal peristaltic pressure waves. Invest Radiol 17:567-572 1:STN:280:BiyC3cfgsVM%3D
21. Richter JE, Wu WC, Johns DN et al (1987) Esophageal manometry in 95 healthy adult volunteers. Dig Dis Sci 32:583-592 1:STN:280:BiiC1cbltlw%3D
22. Passaretti S, Baldi F, Costantini M, Di Martino N, Leo P, Zaninotto G (2000) Manometria esofagea. Farmaci 24:7-18
23. American Gastroenterological Association (1994) Technical review on the clinical use of esophageal manometry. Gastroenterology 107:1865-1884
24. Evans DF, Buckton GK (1999) Clinical measurement in gastroenterology. In: The esophagus. Blackwell Science Ltd, Oxford
25. Cotes JE, Chinn DJ, Roca J, Quanjer PH, Yernault JC (1993) Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 16 [Suppl]:41-52 1:STN:280:ByyB2s%2FmsVQ%3D
26. Quanjer PH, Tammerling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1994) Lung volumes and forced ventilatory flows. Rev Mal Respir 11:5-40
27. Weihrauch TR, Korting GW (1982) Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease. Br J Dermatol 107:325-332 1:STN:280:BiyD3c%2FhsFc%3D
28. Hamel-Roy J, Devroede G, Arhan P, Tetreault L, Duranceau A, Menard HA (1985) Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 88:1-7 1:STN:280:BiqD2M3jvFA%3D
29. Tsianos EB, Drosos AA, Chiras CD, Moutsopulos HM, Kitridou R (1987) Esophageal manometric findings in autoimmune rheumatic diseases: Is scleroderma esophagus a specific entity? Rheumatol Int 7:23-27 1:STN:280:BiiB3szntlw%3D
30. Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: A comparison between CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281-286 1:STN:280:BiaA3czkt1Y%3D
31. Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: A prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870-876 1:STN:280:ByyB2snotFU%3D
32. Lapadula G, Muolo P, Semeraro F et al (1994) Esophageal dysmotility disorders in the rheumatic diseases: A review of 150 patients. Clin Exp Rheumatol 12:515-521 1:STN:280:ByqC2cvotVU%3D
33. Bassotti G, Battaglia E, Debernardi V et al (1997) Esophageal dysfunction in scleroderma. Relationship with disease subsets. Arthritis Rheum 40:2252-2259 1:STN:280:DyaK1c%2FnslentQ%3D%3D
34. Krieg T, Meurer M (1988) Systemic scleroderma: Clinical and pathophysiologic aspects. J Am Acad Dermatol 18:457-481 1:STN:280:BieC2s%2Fhs1Q%3D
35. Koshino Y, Takai T, Kato T et al (1991) Manometric evaluation of esophageal function in progressive systemic sclerosis with special regard to disease severity. Gastroenterol Jpn 26:575-581 1:STN:280:By2D1M%2FlvFY%3D
36. Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911-916 1:STN:280:BiiC2c7gtVY%3D
37. Poormoghim H, Lucas M, Fertig N, Mesdger TA Jr (2000) Systemic sclerosis sine scleroderma. Arthritis Rheum 43:444-451 1:STN:280:DC%2BD3c7lsFGmtg%3D%3D
38. Hostein J, Bost R, Carpentier P, Franco A, Fornet J (1985) Motricité oesophagienne au cours de la maladie de Raynaud, de la sclérodermie systémique et du syndrome de Raynaud présclérodermique. Gastroenterol Clin Biol 9:130-135 1:STN:280:BiqC2MrisVU%3D
39. Kinuya K, Nakajima K, Kinuya S, Michigishi T, Tonami N, Takehara K (2001) Esophageal hypomotility in systemic sclerosis: Close relationship with pulmonary involvement. Ann Nucl Med 15:97-101 1:STN:280:DC%2BD38%2FitVantw%3D%3D
40. Gonzalez R, Storr M, Bloching H, Seige M, Ott R, Allescher HD (2001) Autoantibody profile in systemic sclerosis as markers for esophageal involvement. J Clin Gastroenterol 32:123-127 1:STN:280:DC%2BD3M3jt1GjsA%3D%3D
41. Denis P, Ducrotte P, Pasquis P, Lefrancois R (1981) Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration 42:21-24 1:STN:280:Bi2C38flvFQ%3D
42. Marie I, Dominique S, Levesque H et al (2001) Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 45:346-354 1:STN:280:DC%2BD3Mvls1ChtA%3D%3D
43. Troshinsky MB, Kane GC, Varga J et al (1994) Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med 121:6-10 1:STN:280:ByuB2Mnntlc%3D